168 related articles for article (PubMed ID: 21873808)
21. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
[TBL] [Abstract][Full Text] [Related]
22. Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
Mastrorilli C; Spangler EA; Christopherson PW; Aubry OA; Newton JC; Smith AN; Kennis RA; Weismann JL; Moore PF
Vet Clin Pathol; 2012 Sep; 41(3):412-8. PubMed ID: 22747712
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin A and immunoglobulin G biclonal gammopathy in a dog with multiple myeloma.
Peterson EN; Meininger AC
J Am Anim Hosp Assoc; 1997; 33(1):45-7. PubMed ID: 8974026
[TBL] [Abstract][Full Text] [Related]
24. [Multiple skin plasmocytomas, increased serum IgA and lack of bone marrow lesions (author's transl)].
Bork K; Weigand U
Arch Dermatol Res (1975); 1975 Dec; 254(3):245-52. PubMed ID: 1211974
[TBL] [Abstract][Full Text] [Related]
25. Canine cutaneous lymphoma.
McKeever PJ; Grindem CB; Stevens JB; Osborne CA
J Am Vet Med Assoc; 1982 Mar; 180(5):531-6. PubMed ID: 7061338
[TBL] [Abstract][Full Text] [Related]
26. Use of recombinant human interferon alpha-2a in the management of a dog with epitheliotropic lymphoma.
Tzannes S; Ibarrola P; Batchelor DJ; Burrow RD; Blackwood L
J Am Anim Hosp Assoc; 2008; 44(5):276-82. PubMed ID: 18762565
[TBL] [Abstract][Full Text] [Related]
27. Spurious laboratory results associated with immunoglobulin M gammopathy in a dog with multiple myeloma.
Loane SC; Castillo DA; Peschard ADM; Hall HR; Kortum AJ
J Vet Intern Med; 2022 Nov; 36(6):2181-2186. PubMed ID: 36125290
[TBL] [Abstract][Full Text] [Related]
28. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
29. Nonsecretory multiple myeloma in a dog: immunohistologic and ultrastructural observations.
Marks SL; Moore PF; Taylor DW; Munn RJ
J Vet Intern Med; 1995; 9(1):50-4. PubMed ID: 7891363
[TBL] [Abstract][Full Text] [Related]
30. Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study.
Bavcar S; de Vos J; Kessler M; de Fornel P; Buracco P; Murphy S; Hirschberger J; Argyle DJ
Vet J; 2017 Jun; 224():1-6. PubMed ID: 28697868
[TBL] [Abstract][Full Text] [Related]
31. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004).
Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA
J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855
[TBL] [Abstract][Full Text] [Related]
32. Bone lesions of multiple myeloma in three dogs.
Maeda H; Ozaki K; Abe T; Matsui H; Sano M; Narama I
Zentralbl Veterinarmed A; 1993 Jun; 40(5):384-92. PubMed ID: 8212953
[TBL] [Abstract][Full Text] [Related]
33. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Dunkley S; Gibson J; Iland H; Li C; Joshua D
Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
[TBL] [Abstract][Full Text] [Related]
34. Erythrophagocytic multiple myeloma in a cat.
Webb J; Chary P; Northrup N; Almy F
Vet Clin Pathol; 2008 Sep; 37(3):302-7. PubMed ID: 18761523
[TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma associated with the heavy chains of immunoglobulin A in a dog.
Hoenig M
J Am Vet Med Assoc; 1987 May; 190(9):1191-2. PubMed ID: 3108207
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide for the treatment of leptomeningeal multiple myeloma.
Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I
Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
[No Abstract] [Full Text] [Related]
37. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
Morgan E; O'Connell K; Thomson M; Griffin A
Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous T-cell lymphoma - Sézary syndrome in a Boxer.
Rütgen BC; Flickinger I; Wolfesberger B; Litschauer B; Fuchs-Baumgartinger A; Hammer SE; Saalmüller A; Schwendenwein I
Vet Clin Pathol; 2016 Mar; 45(1):172-8. PubMed ID: 26709607
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
[TBL] [Abstract][Full Text] [Related]
40. [Multiple myeloma with significant multifocal osteolysis in a dog without a detectible gammopathy].
Souchon F; Koch A; Sohns A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2013; 41(6):413-20. PubMed ID: 24326882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
